Lipid Management Handbook Access Code

Dr. Peter Libby is a cardiovascular medicine specialist at Brigham and Women's Hospital (BWH) and the Mallinckrodt Professor of Medicine at Harvard Medical School (HMS). Dr. Libby received his medical degree from the University of California, San Diego School of Medicine. He completed a residency in internal medicine and a fellowship in cardiovascular disease at Peter Bent Brigham Hospital (now BWH). He also completed a research fellowship in cellular physiology at HMS. Dr. Libby is board certified in internal medicine and cardiovascular disease. The author of over 370 peer-reviewed publications, Dr. Libby's clinical and research interests include vascular biology, atherosclerosis and preventative cardiology. The research laboratory that Dr. Libby directs studies the messengers created by the body that may produce arterial plaque and blockages, as well as normal and abnormal function of smooth muscle and endothelial cells. Boston Magazine named Dr. Libby a top cardiologist. His research has received funding from the American Heart Association and National Institutes of Health. Dr. Libby has received research recognitions on four continents including the highest basic research awards from the American Heart Association and American College of Cardiology, the Gold Medal of the European Society of Cardiology, and the Anitchkow award from the European Atherosclerosis Society.

Lipoproteins: Mechanisms for Atherogenesis and Progression of Atherothrombotic Disease
Risk Markers and the Primary Prevention of Cardiovascular Disease
Regulation and Clearance of Apolipoprotein B-Containing Lipoproteins
Impact of Rare and Common Genetic Variants on Lipoprotein Metabolism
Lipoprotein(a)
Overview of General Approach to Management of Elevated Low-Density Lipoprotein Cholesterol and Mixed Dyslipidemia, High Triglycerides, and Low High-Density Lipoprotein Cholesterol
Treatment Guidelines Overview
Dietary Patterns for the Prevention and Treatment of Cardiovascular Disease
Exercise and Lipids
Weight Loss
Nutraceuticals and Functional Foods for Cholesterol Reduction
Statins
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Niacin (Nicotinic Acid)
Fibrates
Omega-3 Fatty Acids
Combination Therapy for Dyslipidemia
Evolving Targets of Therapy: Proprotein Convertase Subtilisin/Kexin 9 Inhibition
Evolving Targets of Therapy: Cholesteryl Ester Transfer Protein Inhibition
Special Patient Populations: Familial Hypercholesterolemia and other Severe Hypercholesterolemias